CRISIL Limited (500092) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of CRISIL Limited ₹1,528, price ₹4,427, upside -65.5%, quality 65 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch CRISIL Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ₹1,786 – ₹6,523 · fair‑value band ₹964.90 – ₹2,300 · the ₹4,427 price screens above the ₹1,528 fair value. Dashed = 300-day average. As of Sep 24, 2026.
CRISIL Limited, an analytical company, together with its subsidiaries, provides ratings, data, research, and analytics and solutions in India, the United States, the United Kingdom, Argentina, Poland, China, Hong Kong, Singapore, and the United Arab Emirates. It operates through three segments: Ratings, Research, and Advisory.
Show more
CRISIL Limited, an analytical company, together with its subsidiaries, provides ratings, data, research, and analytics and solutions in India, the United States, the United Kingdom, Argentina, Poland, China, Hong Kong, Singapore, and the United Arab Emirates. It operates through three segments: Ratings, Research, and Advisory. The Ratings services segment include credit ratings for corporates, banks, bank loans, and small and medium enterprises; credit analysis services; grading services; and analytical services. The Research segment provides research and analytical services, industry reports, customized research assignments, subscription to data services, independent equity research, initial public offering grading, and training services. The Advisory segment offers advisory services; and risk management tools, analytics, and solutions to financial institutions, banks, and corporates. The company was formerly known as The Credit Rating Information Services of India Limited and changed its name to CRISIL Limited in December 2003. CRISIL Limited was founded in 1987 and is headquartered in Mumbai, India.
Stock analysis
CRISIL Limited (500092) currently trades at ₹4,427, while our model-based Fair Value estimate is ₹1,528, 65.5% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹1,639 per share, and 0 of the 13 models we run sit above the ₹4,427 price.
Bear case: the Asset-Based group reads lowest at ₹279.97, and 13 of the 13 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹964.90 (bear) to ₹2,300 (bull), the price of ₹4,427 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 65/100 (solid quality), in the Financial Services sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
CRISIL Limited reported revenue of ₹36.5B in FY2025 versus ₹23.0B in FY2021, a compound +12.2%/yr. Reported net income was ₹7.7B in FY2025, compounding +13.2%/yr from FY2021.
Key figures
Market cap ₹135B (≈ $1.4B) · P/E ratio 41.8 · P/S ratio 8.78 · EPS (TTM) ₹46.91 · Dividend yield 0.6% · Net margin 21.0% · Return on assets (EBIT) 21.9% · Operating margin 21.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 58 out of 100 (medium confidence).
What moves the price
The share trades about 11% below its 52-week high and 20% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −25% fair-value upside, at −65%, 500092 screens richer than that median.
Fair Value models
Bear ₹964.90Fair Value ₹1,528Bull ₹2,300
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (₹14.30 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.93/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+11.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.0%
Start year 2020 (pandemic). Over 10 years: +10.2% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.4%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+17.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+16.5%
Dividend (yield on the price)0.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.16.5% vs 9.8%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.20% → 26%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Financial Data & Stock Exchanges · 51 stocks
Beats the industry median on 3/11 measures
Overall it trails its industry peers.
Valuation
Quality Score65 · Below median
Fair Value upside−71.6% · Bottom 25%
Profitability
Return on assets0.0% · Bottom 25%
Net margin (TTM)18.4% · Below median
Operating margin (TTM)21.7% · Below median
Growth and dividend
Revenue growth19.8% · Above median
Dividend yield (TTM)0.6% · Bottom 25%
Valuation Multiplesvs Financial Data & Stock Exchanges median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "CRISIL Limited Fair Value". https://www.fairvalue-calculator.com/stock/500092
Frequently asked questions
Is CRISIL Limited (500092) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ₹1,528 versus a price of ₹4,427, about −65% upside (overvalued).
What is the fair value of 500092?
Our model-based fair value for CRISIL Limited is ₹1,528 (as of Sep 24, 2026), built from audited fundamentals. The current price: ₹4,427.
What is the quality score of 500092?
CRISIL Limited has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CRISIL Limited (500092)?
Our model-based price target is the fair value of ₹1,528 (as of Sep 24, 2026) from 13 valuation models. Cautious scenario ₹964.90, optimistic scenario ₹2,300. It is a calculation from audited fundamentals, not an analyst target.
What is the CRISIL Limited stock forecast for 2026?
Our models put fair value at ₹1,528, about −65% upside versus a price of ₹4,427 (overvalued). Cautious scenario ₹964.90, optimistic scenario ₹2,300. The calculation is refreshed regularly with new filings.
What is the revenue of CRISIL Limited (500092)?
CRISIL Limited reported trailing-twelve-month revenue of about ₹18.5B (latest available figure, as of Sep 24, 2026).
Does CRISIL Limited pay a dividend?
CRISIL Limited currently shows a dividend yield of about 0.63% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of CRISIL Limited (500092)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CRISIL Limited it is ₹1,528 per share (as of Sep 24, 2026), against a price of ₹4,427. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is CRISIL Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 500092 trades above its calculated fair value: price ₹4,427, fair value ₹1,528, a gap of about −65% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 500092?
No. The price is what the market pays today (₹4,427); the fair value is what the company's own numbers justify (₹1,528). For CRISIL Limited the two are ₹2,899 per share apart. That gap is exactly why we show both numbers side by side.
How much is CRISIL Limited worth?
The market values CRISIL Limited at about ₹135B (market capitalisation, as of Sep 24, 2026). Per share that is ₹4,427; our models calculate a fair value of ₹1,528 per share.
What do the bullish and bearish scenarios say about 500092?
Our models span a range for CRISIL Limited: cautious scenario ₹964.90, base ₹1,528, optimistic ₹2,300 per share (as of Sep 24, 2026, price ₹4,427). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 500092?
CRISIL Limited trades at a price-to-earnings ratio of 41.8 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹1,528 is built from several models across several years. Other multiples: P/B 4.5, P/S 7.3, EV/EBITDA 31.8.
How far is 500092 from its 52-week high?
CRISIL Limited trades at ₹4,427, about 11% below its 52-week high of ₹4,973 and 20% above the low of ₹3,692 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹1,528 is for.
Which stocks are comparable to CRISIL Limited?
From the same area (Financial Services) we also value S&P Global Inc, CME Group, Intercontinental Exchange, Inc, Moody's Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CRISIL Limited stock attractive at the current price?
The data as of Sep 24, 2026: price ₹4,427, calculated fair value ₹1,528 (−65%), Quality Score 65/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 500092 calculated?
We run CRISIL Limited through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹1,528, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. CRISIL Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CRISIL Limited (500092)?
The closing price on Oct 1, 2026 was ₹4,427. Our model-based fair value is ₹1,528, about −65% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CRISIL Limited right now?
The price sits above even our optimistic bull case (₹2,300). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (₹964.90 to ₹2,300) leaves room in how you read the outcome.
Key figures of CRISIL Limited
How large is the market capitalisation of CRISIL Limited (500092)?
The market capitalisation of CRISIL Limited is ₹135B (≈ $1.4B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of CRISIL Limited (500092)?
The price-to-sales ratio of CRISIL Limited is 8.78 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of CRISIL Limited (500092)?
Earnings per share at CRISIL Limited are ₹46.91 (price ÷ EPS = P/E 41.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of CRISIL Limited (500092)?
The dividend yield of CRISIL Limited is 0.6% (payout 59.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of CRISIL Limited (500092)?
The net margin of CRISIL Limited is 21.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of CRISIL Limited (500092)?
On an EBIT basis the return on assets of CRISIL Limited is 21.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of CRISIL Limited (500092)?
The operating margin of CRISIL Limited is 21.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at CRISIL Limited (500092)?
Revenue at CRISIL Limited is growing +19.8% versus a year earlier (3y avg +9.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at CRISIL Limited (500092)?
Earnings per share at CRISIL Limited are growing −14.5% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch CRISIL Limited in the live analysis
One click puts CRISIL Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
